Suchergebnisse - "Wang, Xianguang"

PubPharm (19)

1

Identification of biomarkers and pathways for the SARS-CoV-2 infections in obstructive sleep apnea patients based on machine learning and proteomic analysis

enthalten in: BMC pulmonary medicine | 2024

von Luo, H. | Yan, J. | Gong, R. | +3

2

Identification of biomarkers and pathways for the SARS-CoV-2 infections in obstructive sleep apnea patients based on machine learning and proteomic analysis

enthalten in: BMC pulmonary medicine | 2024

von Luo, H. | Yan, J. | Gong, R. | +3

3

Efficient Adsorbent Derived from Phytolith-Rich Ore for Removal of Tetracycline in Wastewater

enthalten in: ACS omega | 2024

von Liu, X. | Tang, Y. | Wang, X. | +5

4

Fast and sensitive CRISPR detection by minimized interference of target amplification

enthalten in: Nature chemical biology | 2024

von Tong, X. | Zhang, K. | Han, Y. | +7

5

Incomplete immune reconstitution and its predictors in people living with HIV in Wuhan, China

enthalten in: BMC public health | 2023

von Zhang, W. | Yan, J. | Luo, H. | +2

6

Incomplete immune reconstitution and its predictors in people living with HIV in Wuhan, China

enthalten in: BMC public health | 2023

von Zhang, W. | Yan, J. | Luo, H. | +2

7

GIS model for geothermal advantageous target selection

enthalten in: Scientific reports | 2023

von Li, X. | Huang, C. | Chen, W. | +8

8

Investigation of Poly(MM-EM-BM) as Nanosealing Materials in Oil-Based Drilling Fluids : Synthesis and Evaluation

enthalten in: ACS omega | 2023

von Li, D. | Wang, X. | Wang, R. | +3

9

Development and validation of a scoring system for the prediction of HIV drug resistance in Hubei province, China

enthalten in: Frontiers in cellular and infection microbiology | 2023

von Yan, J. | Zhang, W. | Luo, H. | +2

10

A Scoring System Based on Laboratory Parameters and Clinical Features to Predict Unfavorable Treatment Outcomes in Multidrug- and Rifampicin-Resistant Tuberculosis Patients

enthalten in: Infection and drug resistance | 2023

von Yan, J. | Luo, H. | Nie, Q. | +3